2023-10-04 09:59:44
NOVARTIS (CQAW039A2315) – Latin Clinical Trial Center

NOVARTIS (CQAW039A2315)

A 2-treatment period, randomized, placebo-controlled, multicenter parallel-group study to assess the safety of QAW039 when added to existing asthma therapy in GINA steps 3, 4 and 5 patients with uncontrolled asthma

Join the discussion 4 Comments

Leave a Reply